 |
|
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association.
Hyun Jin Kim
J Korean Diabetes. 2018;19(1):35-40. Published online 2018 Apr 13 DOI: https://doi.org/10.4093/jkd.2018.19.1.35
|
|
Citations to this article as recorded by
 Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin
Sang Youl Rhee
Diabetes & Metabolism Journal.2023; 47(6): 769. CrossRef
|